Patents for C12R 1 - Micro-organisms (92,025) |
---|
08/30/1995 | EP0668914A1 Crystallization of m-csf |
08/30/1995 | EP0668913A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
08/30/1995 | EP0668911A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
08/30/1995 | EP0668910A1 Human neuropeptide y-y1 receptor |
08/30/1995 | EP0668780A1 Virulence-specific bacterial dna sequence |
08/30/1995 | EP0668779A1 COMPOSITION PROTECTIVE AGAINST $i(P. MULTOCIDA) PASTEURELLOSIS INFECTION |
08/30/1995 | EP0518999B1 Protein hydrolysates |
08/30/1995 | EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae |
08/30/1995 | EP0469025B1 Improvements in or relating to enhancers |
08/30/1995 | CN1107640A Yeast agglutination genes and yeast containing them |
08/30/1995 | CN1107513A Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same |
08/29/1995 | US5446138 Recombinant DNA coding for a protein with endochitinase activity |
08/29/1995 | US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation |
08/29/1995 | US5445959 Enzyme from microbial source: phthalyl amidase |
08/29/1995 | US5445948 Process for culturing recombinant cells |
08/29/1995 | US5445947 Jojoba wax biosynthesis gene |
08/29/1995 | US5445938 Screening for presence of cancer cells in large bowel tissue sample |
08/29/1995 | US5445933 Strand displacement assay and complex useful therefor |
08/29/1995 | CA2069629C Process for isolating galactose oxidase |
08/29/1995 | CA2053000C Biosynthetic production of 6(r)-[2-(8(s)-hydroxy-2(s), 6(r)-dimethyl-1,2,6,7,8,8a(r)-hexahydronaphthyl)-ethyl]-4 (r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one triol acid by enzymatic hydrolysis of lovastatin acid using an enzyme derived from__lonostachys compactiuscula |
08/29/1995 | CA1336826C Chimeric antibody with specificity to human b cell surface antigen |
08/24/1995 | WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy |
08/24/1995 | WO1995022615A1 A method of preparing a variant of a lipolytic enzyme |
08/24/1995 | WO1995022611A2 Methods and compositions for stimulating bone cells |
08/24/1995 | WO1995022608A1 Galanin receptor, nucleic acids, transformed cells and uses thereof |
08/24/1995 | WO1995022340A1 Methods for altering fertility |
08/24/1995 | WO1995022339A1 Cyclic heptapeptide anti-inflammatory agent |
08/24/1995 | WO1995019435A3 T cell antigen receptor v region proteins and methods of preparation thereof |
08/24/1995 | CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy |
08/24/1995 | CA2183431A1 A method of preparing a variant of a lipolytic enzyme |
08/24/1995 | CA2181827A1 Cyclic heptapeptide anti-inflammatory agent |
08/23/1995 | EP0668360A1 Enzymatic hydrolysis method for the conversion of C-7 sugar to C-7 hydroxyl taxanes |
08/23/1995 | EP0668358A1 Antibiotic WAP-8294A, method for preparing the same and antibacterial composition |
08/23/1995 | EP0668357A1 Vector for integration site independent gene expression in mammalian host cells |
08/23/1995 | EP0668354A1 Cysteine added variants of G-CSF and chemical modifications thereof |
08/23/1995 | EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof |
08/23/1995 | EP0668351A1 Erythropoietin isoforms |
08/23/1995 | EP0668350A1 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
08/23/1995 | EP0668246A1 Strains of acinetobacter species (bicoccum), arthrobacter species and rhodococcus species and a process using the said strains for the biological treatment of oil pollution |
08/23/1995 | EP0667915A1 Protease-stable proteins |
08/23/1995 | EP0667914A1 Fo-1289 substance and its production |
08/23/1995 | EP0667911A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
08/23/1995 | EP0667910A1 A bacillus promoter derived from a variant of a bacillus licheniformis x-amylase promoter |
08/23/1995 | EP0667909A1 Biotechnological method of producing biotin |
08/23/1995 | EP0667908A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
08/23/1995 | EP0667906A1 $g(b)-KETOACYL-ACP SYNTHETASE II GENES FROM PLANTS |
08/23/1995 | EP0667904A1 Suppressor and progenitor cells |
08/23/1995 | EP0667902A1 Cdr grafted humanised chimeric t-cell antibodies |
08/23/1995 | EP0667899A1 Mutated growth factor receptor as medicament and its use for treating cancer |
08/23/1995 | EP0667872A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
08/23/1995 | EP0667869A1 Assay for inhibitors of farnesyl-protein transferase |
08/23/1995 | EP0667853A1 Method of synthesising phytosphingosine-containing ceramides and cosmetic compositions comprising them |
08/23/1995 | EP0667780A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
08/23/1995 | EP0522010B1 Bcrf1 antagonists for treating epstein-barr virus infections |
08/23/1995 | EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b |
08/23/1995 | EP0494929B1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
08/23/1995 | EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
08/23/1995 | CN1107179A Method for the production of L-threonine by fermentation |
08/22/1995 | US5444164 TGF-β induced gene |
08/22/1995 | US5444159 Purification of a pertussis outer membrane protein |
08/22/1995 | US5444158 Merosin, nucleic acids encoding, fragments and uses thereof |
08/22/1995 | US5444155 Molecules with antibody combining sites that induce asymmetry |
08/22/1995 | US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site |
08/22/1995 | US5444151 Platelet derived growth factor antagonists |
08/22/1995 | US5444043 Cyclic depsipeptide non-steroidal antiinflammatory agent |
08/22/1995 | US5443979 Synergistic mixture |
08/22/1995 | US5443978 Cloned dna |
08/22/1995 | US5443973 Method of producing α-hydroxyisobutyramide from acetone cyanohydrin by nitril hydratase |
08/22/1995 | US5443972 Fermentation of Streptomyces |
08/22/1995 | US5443969 In vivo system for expression and packaging a genetic engineered single stranded RNA of unlimited length into pseudovirus particles comprised of plant viral coat proteins; storage stability, ribonuclease resistant |
08/22/1995 | US5443968 Fed batch culture method for protein secreting cells |
08/22/1995 | US5443966 Expression of tetanus toxin fragment C |
08/22/1995 | US5443965 Peptide antigens used in diagnosis |
08/22/1995 | US5443962 Methods of identifying inhibitors of cdc25 phosphatase |
08/22/1995 | US5443957 Cancer diagnosis |
08/22/1995 | US5443953 Genetic engineering; diagnosis, therapy |
08/22/1995 | US5443827 Chimeric molecule; anticoagulants |
08/22/1995 | US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis |
08/22/1995 | CA2032742C Method of producing brassinosteroids |
08/22/1995 | CA2012013C Antitumor antibiotic bmy-41339 |
08/22/1995 | CA1336763C Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement |
08/17/1995 | WO1995021933A1 L-ascorbic acid production in microorganisms |
08/17/1995 | WO1995021928A1 Process for the production of a heterologous protein from a methylotrophic yeast |
08/17/1995 | WO1995021927A2 Targeting gene therapy |
08/17/1995 | WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins |
08/17/1995 | WO1995021925A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay |
08/17/1995 | WO1995021921A1 Mammalian thymokine genes |
08/17/1995 | WO1995021920A1 Hematopoietic protein and materials and methods for making it |
08/17/1995 | WO1995021917A1 Mammalian cell cycle protein |
08/17/1995 | WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
08/17/1995 | WO1995021910A1 Modification of filamentous microorganisms |
08/17/1995 | WO1995021860A1 Methods for variation of chromatin condensation |
08/17/1995 | WO1995021858A2 Mosaic polypeptide and methods for detecting the hepatitis e virus |
08/17/1995 | WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
08/17/1995 | WO1995007994A3 Recombinant alphavirus vectors |
08/17/1995 | DE4420782C1 New DNA encoding a 2-oxoglutarate-malate translocator |
08/17/1995 | CA2183362A1 Mosaic polypeptide and methods for detecting the hepatitis e virus |
08/17/1995 | CA2183266A1 Hematopoietic protein and materials and methods for making it |
08/17/1995 | CA2183254A1 Mammalian cell cycle protein |
08/17/1995 | CA2183166A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay |